Understanding how specific NRAS mutations interact with BRAF in melanoma
Defining the biochemical properties and implications of NRAS mutant-specific BRAF interactions in melanoma
This study is looking at how certain changes in the NRAS gene interact with BRAF proteins in melanoma, which is a type of skin cancer, to help us understand how these changes might make the cancer grow and resist treatment.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10826520 on NIH RePORTER |
What this research studies
This research investigates the biochemical interactions between specific NRAS mutations and BRAF proteins in melanoma, a type of skin cancer. By examining how these mutations affect cellular signaling pathways that promote cancer growth, the study aims to uncover the mechanisms that drive melanoma development. The approach includes molecular dynamics simulations and experimental assays to analyze the binding properties of NRAS mutants with BRAF. This could lead to a better understanding of how these mutations contribute to cancer progression and treatment resistance.
Who could benefit from this research
Good fit: Ideal candidates for this research are melanoma patients who have been identified with NRAS mutations.
Not a fit: Patients without NRAS mutations or those with other types of cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more targeted therapies for melanoma patients with specific NRAS mutations.
How similar studies have performed: Previous research has shown promising results in understanding RAS mutations in cancer, indicating that this approach could yield valuable insights.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Lew, Rachel E. — Ohio State University
- Study coordinator: Lew, Rachel E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.